XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/texas/2019/04/30/emtora-biosciences-turns-sights-on-rare-genetic-disease-new-funding/60%Monthly2019-04-30 21:25
https://xconomy.com/seattle/2019/04/30/washington-vc-watch-pattern-computer-chatbox-joylux-more/60%Monthly2019-04-30 20:08
https://xconomy.com/detroit-ann-arbor/2019/04/30/ford-lincoln-owners-can-get-amazon-packages-delivered-to-their-cars/60%Monthly2019-05-01 12:37
https://xconomy.com/boston/2019/04/30/anti-cheating-startup-examity-gets-90m-to-advance-edtech-security/60%Monthly2019-04-30 15:13
https://xconomy.com/wisconsin/2019/04/30/roche-spinout-nimble-therapeutics-bags-10m-to-find-new-peptide-drugs/60%Monthly2019-04-30 14:30
https://xconomy.com/texas/2019/04/30/cliently-moves-to-san-antonio-with-1m-round-led-by-active-capital/60%Monthly2019-04-26 15:18
https://xconomy.com/boston/2019/04/30/exosomes-head-to-wall-street-as-codiak-biosciences-lines-up-ipo/60%Monthly2019-04-30 12:19
https://xconomy.com/san-francisco/2019/04/30/another-568m-and-a-7b-valuation-for-automation-firm-uipath/60%Monthly2019-04-30 04:50
https://xconomy.com/san-diego/2019/04/30/vividion-raises-82m-to-advance-small-molecule-drugs-to-the-clinic/60%Monthly2019-04-30 08:04
https://xconomy.com/san-diego/2019/04/29/takeda-unites-san-diego-operations-at-new-biotech-style-rd-center/60%Monthly2019-04-30 03:55
https://xconomy.com/seattle/2019/04/29/baldo-leaves-genentech-for-adaptive-bio-chief-medical-officer-post/60%Monthly2019-04-29 22:45
https://xconomy.com/new-york/2019/04/29/immunomedics-chief-medical-officer-robert-iannone-to-depart/60%Monthly2019-04-30 14:29
https://xconomy.com/texas/2019/04/29/peloton-therapeutics-plans-ipo-for-kidney-cancer-drug-clinical-trials/60%Monthly2019-04-29 19:06
https://xconomy.com/national/2019/04/29/finding-your-startup-lawyer-what-every-entrepreneur-should-know/60%Monthly2019-04-29 17:38
https://xconomy.com/seattle/2019/04/26/appsheet-raises-15m-to-help-people-who-arent-pro-coders-build-apps/60%Monthly2019-04-27 01:30
https://xconomy.com/indiana/2019/04/26/elanco-bolsters-pet-products-pipeline-with-234m-deal-for-aratana/60%Monthly2019-04-26 20:15
https://xconomy.com/texas/2019/04/26/animal-rescue-groups-pga-stryve-biltong-novo-labs-more-tx-tech/60%Monthly2019-04-26 19:16
https://xconomy.com/san-diego/2019/04/26/connect-san-diego-venture-group-announce-plan-to-merge-operations/60%Monthly2019-04-26 18:21
https://xconomy.com/boston/2019/04/26/boston-tech-watch-workbar-modo-locus-robotics-zagster-more/60%Monthly2019-04-26 12:46
https://xconomy.com/national/2019/04/26/bio-roundup-biogens-strategy-drug-price-convo-nash-news-more/60%Monthly2019-04-26 13:46
https://xconomy.com/seattle/2019/04/25/francisco-partners-buys-stake-in-payscale-exiting-warburg-pincus/60%Monthly2019-04-26 18:45
https://xconomy.com/san-francisco/2019/04/25/with-103m-raise-edtech-firm-coursera-graduates-to-unicorn-status/60%Monthly2019-04-25 20:05
https://xconomy.com/boston/2019/04/25/histogenics-exec-kelley-moves-to-x4-pharma-as-chief-medical-officer/60%Monthly2019-04-25 19:26
https://xconomy.com/new-york/2019/04/25/dave-more-chips-on-aisle-3-walmart-opens-ai-enabled-store-in-ny/60%Monthly2019-04-25 18:25
https://xconomy.com/seattle/2019/04/25/gates-foundation-xinova-tie-up-aimed-at-using-data-to-fight-malaria/60%Monthly2019-04-25 16:56
https://xconomy.com/san-diego/2019/04/25/roswell-organovo-more-xconomy-awards-innovation-at-the-intersection-finalists/60%Monthly2019-04-26 15:08
https://xconomy.com/san-francisco/2019/04/25/after-nash-drugs-2nd-failure-gilead-pins-hopes-on-combo-therapies/60%Monthly2019-04-25 19:30
https://xconomy.com/texas/2019/04/25/to-help-boost-female-led-startups-more-women-join-investor-ranks/60%Monthly2019-04-24 22:55
https://xconomy.com/boston/2019/04/25/announcing-net50-the-roots-and-future-of-the-internet/60%Monthly2019-04-24 16:44
https://xconomy.com/detroit-ann-arbor/2019/04/25/midwest-growth-capital-symposium-to-feature-vc-university-seminar/60%Monthly2019-04-24 19:13
https://xconomy.com/san-diego/2019/04/24/avidity-biosciences-gets-35m-in-immunology-rd-deal-with-eli-lilly/60%Monthly2019-04-29 23:07
https://xconomy.com/wisconsin/2019/04/24/northstar-secures-75m-as-medical-radioisotope-competition-revs-up/60%Monthly2019-04-25 16:00
https://xconomy.com/san-diego/2019/04/24/forge-therapeutics-basilea-sign-deal-to-pursue-new-antibiotics/60%Monthly2019-04-24 19:20
https://xconomy.com/texas/2019/04/24/rackspace-hires-dallas-transit-exec-jones-to-replace-eazor-as-ceo/60%Monthly2019-04-25 16:02
https://xconomy.com/boston/2019/04/24/cybersecurity-firm-digital-guardian-gets-30m-boost-hires-execs/60%Monthly2019-04-24 15:42
https://xconomy.com/boston/2019/04/24/biogen-taking-its-failures-seriously-keeps-focus-on-neuroscience/60%Monthly2019-04-24 17:43
https://xconomy.com/san-francisco/2019/04/24/the-designers-ai-apprentice-starck-autodesk-create-ai-chair/60%Monthly2019-04-24 13:56
https://xconomy.com/new-york/2019/04/23/tevas-approved-migraine-drug-fails-again-to-blunt-rarer-headache/60%Monthly2019-04-23 22:48
https://xconomy.com/seattle/2019/04/23/ci-security-raises-9-6m-to-help-customers-manage-cyber-threats/60%Monthly2019-04-23 21:44
https://xconomy.com/wisconsin/2019/04/23/imbed-biosciences-gets-2m-boost-for-silver-based-wound-dressings/60%Monthly2019-04-23 21:18
https://xconomy.com/boston/2019/04/23/censinet-takes-off-with-7-8m-to-track-cyber-risks-in-healthcare/60%Monthly2019-04-23 14:14
https://xconomy.com/national/2019/04/23/join-xconomy-for-our-8th-annual-napa-summit-june-13-14/60%Monthly2019-05-10 13:02
https://xconomy.com/san-diego/2019/04/23/servicenow-alums-perspectium-adds-8m-more-for-integration-tools/60%Monthly2019-04-23 07:19
https://xconomy.com/national/2019/04/23/special-report-2019-blockchain-outlook-reality-check/60%Monthly2019-04-23 14:16
https://xconomy.com/boston/2019/04/23/can-we-afford-to-be-cured-a-conversation-with-icers-steve-pearson/60%Monthly2019-04-23 23:10
https://xconomy.com/detroit-ann-arbor/2019/04/23/aptiv-expands-driverless-car-testing-opens-chinese-mobility-center/60%Monthly2019-04-23 11:54
https://xconomy.com/san-francisco/2019/04/22/pfizers-dimitry-nuyten-jumps-to-aduro-for-chief-medical-officer-job/60%Monthly2019-04-22 22:52
https://xconomy.com/boulder-denver/2019/04/22/cerebral-therapeutics-names-lisa-shafer-chief-scientific-officer/60%Monthly2019-04-22 22:48
https://xconomy.com/texas/2019/04/22/chevrons-burger-on-energy-innovation-houstons-growing-tech-scene/60%Monthly2019-04-22 20:34
https://xconomy.com/seattle/2019/04/22/magnix-eviation-partner-to-develop-electric-plane-for-short-flights/60%Monthly2019-04-22 19:48
https://xconomy.com/seattle/2019/04/22/xconomys-seattle-event-to-explore-tech-convergence-in-life-sciences/60%Monthly2019-04-24 18:15
https://xconomy.com/san-diego/2019/04/22/poseida-to-advance-car-t-for-myeloma-with-novartis-led-142m-round/60%Monthly2019-04-23 16:10
https://xconomy.com/texas/2019/04/22/upland-software-acquires-email-marketing-business-postup-for-35m/60%Monthly2019-04-22 16:38
https://xconomy.com/new-york/2019/04/22/merck-wins-fda-nod-for-combo-therapy-in-advanced-kidney-cancer/60%Monthly2019-04-22 13:46
https://xconomy.com/detroit-ann-arbor/2019/04/22/msu-announces-new-student-vc-fund-winners-of-inaugural-pitch-contest/60%Monthly2019-04-22 13:08
https://xconomy.com/seattle/2019/04/19/terraclear-raises-4-7m-for-machine-designed-to-pick-rocks-from-soil/60%Monthly2019-04-19 23:31
https://xconomy.com/texas/2019/04/19/imandra-innovapptive-nesh-kroger-delivery-robots-more-tx-tech/60%Monthly2019-04-19 18:33
https://xconomy.com/boston/2019/04/19/boston-tech-watch-algorand-owl-labs-cyber-madness-zapata/60%Monthly2019-04-18 20:31
https://xconomy.com/national/2019/04/19/bio-roundup-nationwides-rise-a-surgeons-quest-crispr-usa-more/60%Monthly2019-04-23 11:58
https://xconomy.com/boston/2019/04/18/ksq-therapeutics-taps-blueprints-wolf-for-chief-medical-officer/60%Monthly2019-04-18 22:32
https://xconomy.com/texas/2019/04/18/san-antonio-wound-care-company-eyes-another-initial-public-offering/60%Monthly2019-04-18 22:31
https://xconomy.com/seattle/2019/04/18/bardy-diagnostics-to-ramp-up-cardiac-monitor-sales-with-35m-raise/60%Monthly2019-04-18 22:12
https://xconomy.com/new-york/2019/04/18/hookipas-ipo-raises-84m-for-drugs-to-reprogram-the-immune-system/60%Monthly2019-04-18 20:57
https://xconomy.com/texas/2019/04/18/accenture-invests-in-san-antonio-government-cybersecurity-operations/60%Monthly2019-04-22 19:23
https://xconomy.com/detroit-ann-arbor/2019/04/18/humatics-vecna-partner-to-improve-navigation-of-self-driving-robots/60%Monthly2019-04-18 21:33
https://xconomy.com/boston/2019/04/18/former-sigilion-exec-paul-wotton-named-obsidian-therapeutics-ceo/60%Monthly2019-04-18 14:10
https://xconomy.com/new-york/2019/04/18/the-future-of-new-york-life-sciences/60%Monthly2019-04-18 13:54
https://xconomy.com/wisconsin/2019/04/18/redox-wrangles-33m-to-become-healthcares-go-to-data-integrator/60%Monthly2019-05-03 17:55
https://xconomy.com/boston/2019/04/18/its-tough-to-find-drugs-to-bind-to-rna-arrakis-nabs-75m-to-help/60%Monthly2019-04-18 21:44
https://xconomy.com/boston/2019/04/18/100m-for-talaris-gives-surgeon-a-shot-to-reinvent-organ-transplants/60%Monthly2019-04-18 21:34
https://xconomy.com/texas/2019/04/17/new-microsoft-intel-accelerator-seeks-tech-to-make-houston-smart/60%Monthly2019-04-18 21:35
https://xconomy.com/detroit-ann-arbor/2019/04/17/medhealth-summit-brings-together-cross-border-innovators-and-experts/60%Monthly2019-04-17 18:53
https://xconomy.com/boston/2019/04/17/pathai-raises-60m-in-quest-to-be-ai-assistant-in-the-exam-room/60%Monthly2019-04-18 21:35
https://xconomy.com/san-diego/2019/04/17/turning-point-prices-ipo-raising-166m-to-test-cancer-drugs/60%Monthly2019-04-17 15:24
https://xconomy.com/texas/2019/04/17/slingshot-adds-5m-for-software-that-monitors-disasters-defense/60%Monthly2019-04-17 13:05
https://xconomy.com/boston/2019/04/17/cyber-madness-photos-takeaways-honeypots-espionage-plots-more/60%Monthly2019-04-17 14:36
https://xconomy.com/san-diego/2019/04/16/qualcomm-apple-end-worldwide-legal-fights-with-settlement-agreement/60%Monthly2019-04-17 14:07
https://xconomy.com/san-francisco/2019/04/16/former-jazz-pharma-exec-vanhove-named-surrozen-chief-medical-officer/60%Monthly2019-04-17 17:17
https://xconomy.com/boston/2019/04/16/janssens-scott-plevy-joins-synlogic-as-chief-scientific-officer/60%Monthly2019-04-16 22:18
https://xconomy.com/seattle/2019/04/16/seattles-outreach-joins-unicorn-ranks-with-114m-funding-round/60%Monthly2019-05-15 23:08
https://xconomy.com/san-francisco/2019/04/16/6sense-raises-27m-to-uncover-hidden-interests-of-b2b-buyers/60%Monthly2019-04-16 21:19
https://xconomy.com/seattle/2019/04/16/founders-co-op-raises-25m-to-back-more-pacific-northwest-startups/60%Monthly2019-04-16 19:26
https://xconomy.com/seattle/2019/04/16/alder-bio-picks-abbvies-nadia-dac-for-chief-commercial-officer/60%Monthly2019-04-16 16:09
https://xconomy.com/boston/2019/04/16/kaleido-bio-names-johan-van-hylckama-vlieg-chief-scientific-officer/60%Monthly2019-04-16 22:10
https://xconomy.com/detroit-ann-arbor/2019/04/16/metamotos-jeff-blackburn-on-av-testing-and-why-waymo-leads-the-pack/60%Monthly2019-04-16 12:21
https://xconomy.com/boston/2019/04/16/flagship-pioneering-unveils-kintais-gut-approach-to-treating-disease/60%Monthly2019-04-16 03:01
https://xconomy.com/national/2019/04/16/insitro-lands-three-year-deal-with-gilead-to-find-new-nash-drugs/60%Monthly2019-04-16 11:00
https://xconomy.com/boston/2019/04/16/alzheimers-gene-therapy-more-agenda-for-whats-hot-on-may-21/60%Monthly2019-04-18 20:45
https://xconomy.com/texas/2019/04/16/everlywell-austin-maker-of-at-home-lab-tests-nets-50-million/60%Monthly2019-04-16 18:17
https://xconomy.com/seattle/2019/04/15/show-me-the-money-seattles-showdigs-gets-3m-for-real-estate-tools/60%Monthly2019-04-15 21:10
https://xconomy.com/san-diego/2019/04/15/as-drug-resistance-grows-amplyx-tests-new-antifungal-drug/60%Monthly2019-04-15 16:47
https://xconomy.com/texas/2019/04/15/solarwinds-moki-nimbox-got-rice-business-plan-more-tx-tech/60%Monthly2019-04-15 16:40
https://xconomy.com/san-francisco/2019/04/15/achaogen-eyes-sale-in-bankruptcy-auction-a-year-after-fda-approval/60%Monthly2019-04-15 15:49
https://xconomy.com/new-york/2019/04/15/another-week-another-gene-therapy-buyout-catalent-pays-1-2b-for-paragon/60%Monthly2019-04-15 12:49
https://xconomy.com/raleigh-durham/2019/04/15/hatteras-launches-new-fund-with-94m-for-life-science-investments/60%Monthly2019-04-13 04:47
https://xconomy.com/national/2019/04/15/how-an-ohio-kids-hospital-quietly-became-ground-zero-for-gene-therapy/60%Monthly2019-04-22 18:39
https://xconomy.com/boston/2019/04/12/alnylam-makes-case-for-2nd-rnai-drug-at-big-liver-disease-meeting/60%Monthly2019-04-12 22:00
https://xconomy.com/texas/2019/04/12/beyond-oil-bahrain-houston-can-find-common-ground-on-innovation/60%Monthly2019-04-12 19:12
https://xconomy.com/san-francisco/2019/04/12/lyft-uber-and-the-changing-disclosure-rules-for-unicorn-ipos/60%Monthly2019-04-12 18:51
https://xconomy.com/new-york/2019/04/12/thwarting-opposition-bristol-gets-shareholder-ok-for-74b-celgene-buyout/60%Monthly2019-04-12 15:46
https://xconomy.com/detroit-ann-arbor/2019/04/12/toyota-ford-gm-and-sae-form-automated-vehicle-safety-consortium/60%Monthly2019-04-12 12:39
https://xconomy.com/national/2019/04/12/bio-roundup-easl-does-it-alnylams-bff-gene-therapy-deals-more/60%Monthly2019-04-12 11:00
https://xconomy.com/boston/2019/04/12/boston-tech-startups-tufin-facebook-righthand-diameter-jebbit/60%Monthly2019-04-15 14:46
https://xconomy.com/san-diego/2019/04/11/san-diego-life-sciences-roundup-evofem-cullgen-brainleap-more/60%Monthly2019-04-12 03:51
https://xconomy.com/wisconsin/2019/04/11/wi-watchlist-dotcom-therapy-nordic-uwm-epic/60%Monthly2019-04-11 21:06
https://xconomy.com/new-york/2019/04/11/intercept-touts-a-smaller-piece-of-its-nash-trial-at-liver-conference/60%Monthly2019-04-11 20:21
https://xconomy.com/raleigh-durham/2019/04/11/ribometrix-appoints-john-reardon-chief-scientific-officer/60%Monthly2019-04-11 18:42
https://xconomy.com/boston/2019/04/11/former-shire-rd-head-busch-named-cyclerion-chief-innovation-officer/60%Monthly2019-04-12 18:31
https://xconomy.com/san-diego/2019/04/11/evonexus-gets-bank-investment-firm-backing-for-fintech-incubator/60%Monthly2019-04-11 16:01
https://xconomy.com/san-diego/2019/04/11/xconomy-awards-san-diego-diversity-finalists-are-scaling-up-empowerment/60%Monthly2019-04-11 16:28
https://xconomy.com/raleigh-durham/2019/04/11/askbio-reels-in-235m-to-advance-gene-therapy-clinical-trials/60%Monthly2019-04-11 14:45
https://xconomy.com/boston/2019/04/11/affectiva-raises-26m-to-get-self-driving-cars-to-know-your-mood/60%Monthly2019-04-11 15:18
https://xconomy.com/texas/2019/04/11/active-capital-leads-1-8m-round-for-back-offices-ai-bookkeeping/60%Monthly2019-04-11 04:52
https://xconomy.com/san-francisco/2019/04/10/jintel-health-taps-former-zimmer-biomet-exec-dvorak-for-ceo-post/60%Monthly2019-04-11 15:30
https://xconomy.com/raleigh-durham/2019/04/10/chimerix-names-former-endocyte-exec-michael-sherman-ceo/60%Monthly2019-04-13 05:42
https://xconomy.com/detroit-ann-arbor/2019/04/10/roundup-mispringboard-free-ql-demo-day-help-detroited411-more/60%Monthly2019-04-10 18:11
https://xconomy.com/national/2019/04/09/senators-grill-pharmacy-benefit-execs-about-skyrocketing-drug-prices/60%Monthly2019-04-10 01:15
https://xconomy.com/seattle/2019/04/09/apana-gulps-down-11m-to-help-costco-other-clients-track-water-use/60%Monthly2019-04-09 22:19
https://xconomy.com/boston/2019/04/09/dynamicare-health-gamifies-staying-clean-for-recovering-addicts/60%Monthly2019-05-22 20:27
https://xconomy.com/texas/2019/04/09/austin-vc-firm-liveoak-venture-partners-closes-second-105m-fund/60%Monthly2019-04-09 14:37
https://xconomy.com/national/2019/04/09/vc-trends-in-2019-more-money-fewer-deals-but-women-still-get-less/60%Monthly2019-04-09 15:35
https://xconomy.com/san-francisco/2019/04/08/fda-refuses-to-review-zogenix-seizure-drug-says-file-not-complete/60%Monthly2019-04-09 01:12
https://xconomy.com/seattle/2019/04/08/risklens-raises-20m-for-software-that-quantifies-cyber-risk/60%Monthly2019-04-09 14:13
https://xconomy.com/boston/2019/04/08/translate-bio-names-richard-wooster-chief-scientific-officer/60%Monthly2019-04-08 19:12
https://xconomy.com/boston/2019/04/08/acceleron-pharmas-chief-medical-officer-robert-zeldin-departs/60%Monthly2019-04-08 19:09
https://xconomy.com/texas/2019/04/08/cdr-buys-majority-stake-in-san-antonios-sirius-computer-solutions/60%Monthly2019-04-08 16:04
https://xconomy.com/new-york/2019/04/08/trevi-therapeutics-files-for-ipo-to-fund-anti-itching-drug-rd/60%Monthly2019-04-08 15:42
https://xconomy.com/boston/2019/04/08/klaviyo-puts-google-facebook-amazon-on-notice-with-150m-raise/60%Monthly2019-04-08 13:20
https://xconomy.com/national/2019/04/08/four-things-every-smart-startup-should-do-as-it-scales/60%Monthly2019-04-08 12:57
https://xconomy.com/detroit-ann-arbor/2019/04/08/global-detroit-u-m-team-on-program-to-boost-immigrant-led-startups/60%Monthly2019-04-09 17:23
https://xconomy.com/boston/2019/04/08/alnylam-gets-800m-from-regeneron-to-bring-rnai-to-eye-brain-diseases/60%Monthly2019-04-08 11:54
https://xconomy.com/san-diego/2019/04/05/san-diego-tech-roundup-bitmo-dvele-cybersecurity-report-more/60%Monthly2019-04-05 22:03
https://xconomy.com/new-york/2019/04/05/ex-seres-executive-roger-pomerantz-appointed-contrafect-ceo/60%Monthly2019-04-08 19:19
https://xconomy.com/boston/2019/04/05/braeburn-pharmas-malamut-joins-collegium-as-chief-medical-officer/60%Monthly2019-04-05 19:44
https://xconomy.com/new-york/2019/04/05/celgene-files-for-fda-approval-of-blood-disease-drug/60%Monthly2019-04-08 12:13
https://xconomy.com/texas/2019/04/05/tx-tech-made-in-jog-ai-vital-farms-bbl-advice-from-mark-cuban/60%Monthly2019-04-05 13:27
https://xconomy.com/boston/2019/04/05/boston-tech-watch-huawei-care-com-cambridge-blockchain-paypal/60%Monthly2019-04-05 01:17
https://xconomy.com/national/2019/04/05/bio-roundup-gottliebs-goodbye-aacr-recap-migraine-drug-fight-more/60%Monthly2019-04-05 10:29
https://xconomy.com/seattle/2019/04/04/skills-pills-hospital-bills-amazon-debuts-alexa-health-features/60%Monthly2019-04-05 13:37
https://xconomy.com/texas/2019/04/04/ut-health-san-antonio-plans-new-accelerator-for-faculty-research/60%Monthly2019-04-04 18:28
https://xconomy.com/wisconsin/2019/04/04/c-motive-powers-up-with-2m-to-launch-reimagined-electric-motor/60%Monthly2019-04-04 16:04
https://xconomy.com/detroit-ann-arbor/2019/04/04/as-avs-rev-up-the-data-privacy-fight-could-shift-to-your-car/60%Monthly2019-04-04 13:08
https://xconomy.com/boston/2019/04/04/report-biogen-novartis-should-drop-prices-of-billon-dollar-sma-drugs/60%Monthly2019-04-04 15:04
https://xconomy.com/san-francisco/2019/04/03/ngm-bios-ipo-raises-107m-as-nash-drug-continues-clinical-testing/60%Monthly2019-04-04 13:49
https://xconomy.com/san-diego/2019/04/03/reveal-biosciences-gets-intels-backing-on-ai-powered-pathology/60%Monthly2019-04-04 00:06
https://xconomy.com/seattle/2019/04/03/uw-prof-entrepreneur-shwetak-patel-awarded-acm-prize-in-computing/60%Monthly2019-04-03 22:25
https://xconomy.com/san-diego/2019/04/03/charles-river-labs-says-it-will-close-san-diego-research-facility/60%Monthly2019-04-03 19:26
https://xconomy.com/san-diego/2019/04/03/xconomy-awards-san-diego-ceo-finalists-show-how-to-build-value/60%Monthly2019-04-03 15:47
https://xconomy.com/boston/2019/04/03/procrastinators-special-save-on-tickets-for-cyber-madness-on-monday/60%Monthly2019-04-02 16:45
https://xconomy.com/national/2019/04/03/aacr-2019-roundup-notes-from-a-weekend-of-early-stage-cancer-results/60%Monthly2019-04-03 10:47
https://xconomy.com/boston/2019/04/03/dyne-therapeutics-emerges-with-50m-to-take-on-rare-muscle-disease/60%Monthly2019-04-03 12:05
https://xconomy.com/seattle/2019/04/02/lear-to-acquire-seattle-connected-vehicle-tech-firm-xevo-for-320m/60%Monthly2019-04-04 13:16
https://xconomy.com/seattle/2019/04/02/seattle-venture-capital-watch-crelate-cyemptive-blue-canoe-more/60%Monthly2019-04-02 19:12
https://xconomy.com/texas/2019/04/02/executive-director-of-alamo-angels-resigns-to-focus-on-seed-fund-job/60%Monthly2019-04-02 16:24
https://xconomy.com/boston/2019/04/02/vertex-pharmaceuticals-taps-ortho-clinicals-wagner-for-cfo-post/60%Monthly2019-04-02 15:07
https://xconomy.com/new-york/2019/04/02/petra-pharma-names-albert-yu-chief-medical-officer/60%Monthly2019-04-02 14:56
https://xconomy.com/boston/2019/04/02/formlabs-3d-printers-form3-form3l-prototyping-resin-plastic/60%Monthly2019-04-02 22:10
https://xconomy.com/national/2019/04/02/facepalm-bug-is-a-jarring-wake-up-call-and-not-just-for-apple/60%Monthly2019-04-02 12:59
https://xconomy.com/boston/2019/04/02/xconomy-is-hiring-a-digital-product-manager-apply-here/60%Monthly2019-04-01 19:58
https://xconomy.com/boston/2019/04/02/ezcater-celebrates-unicorn-status-after-150m-funding-round/60%Monthly2019-04-02 11:54
https://xconomy.com/boston/2019/04/01/surface-oncology-appoints-wendy-dwyer-chief-business-officer/60%Monthly2019-04-02 14:43
https://xconomy.com/san-francisco/2019/04/01/genentechs-aaron-osborne-joins-adverum-as-chief-medical-officer/60%Monthly2019-04-01 23:44
https://xconomy.com/texas/2019/04/01/chevron-tech-medical-informatics-activtrak-linear-more-tx-tech/60%Monthly2019-04-01 16:55
https://xconomy.com/detroit-ann-arbor/2019/04/01/after-scoring-new-capital-fifth-eye-prepares-to-seek-fda-approval/60%Monthly2019-04-01 19:06
https://xconomy.com/texas/2019/04/01/thoma-bravo-acquires-san-antonios-mailgun-as-scaleworks-takes-exit/60%Monthly2019-04-01 18:51
https://xconomy.com/detroit-ann-arbor/2019/04/01/farmwise-and-roush-partner-to-develop-robots-that-weed-farm-fields/60%Monthly2019-04-05 20:20
https://xconomy.com/boston/2019/04/01/toast-rings-up-250m-pledges-1b-for-software-and-hardware-rd/60%Monthly2019-04-01 10:55
https://xconomy.com/new-york/2019/04/01/springworks-armed-with-ex-pfizer-cancer-drugs-reloads-with-125m/60%Monthly2019-04-01 12:25
https://xconomy.com/boston/2019/04/01/novartis-adds-inflammation-drugs-to-pipeline-with-deal-for-ifm-tre/60%Monthly2019-04-01 12:18